Patients with branch retinal vein occlusion saw significant differences in systolic, diastolic and arterial blood pressure compared with control patients over a 24-hour period, according to findings ...

Scientists have found that laser therapy is equivalent to two different dosages of corticosteroid medications for treating vision loss from the blockage of small veins in the back of the eye, a ...

To investigate the role of the topographical distribution of temporal retinal vessels in anatomical predisposition to branch retinal vein occlusion (BRVO). Sixty patients with BRVO and 60 control ...

While the current therapies are effective for treating branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO), they are inadequate for long-term treatment in clinical practice, ...

Patients with branch retinal vein occlusion (BRVO) who have been treated with either bevacizumab or ranibizumab experienced significant gain in visual acuity. Moreover, an as-needed dosing strategy ...

Paul Teutul Sr. Partners to Promote Company’s First Charitable Mobile ServiceVIRGINIA BEACH, Va., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Bravo Multinational, Inc. (OTC ...

Scientists have found that laser therapy is equivalent to two different dosages of corticosteroid medications for treating vision loss from the blockage of small veins in the back of the eye, a ...